Screener Summaries Updates Institutions Sign In More Updates › Other Events › RGNT Other Events · Jun 8, 2026
Regentis Biomaterials Ltd. announced the commencement of European surgeon training for GelrinC in knee cartilage repair RGNT Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd. announced the commencement of European surgeon training for GelrinC in knee cartilage repair. This initiative is part of the company's accelerating preparations for a commercial launch.
More from Regentis Biomaterials Ltd. Regentis raises $6.5M in private placement, reports $2.6M net loss for first half 2026 Sep 11, 2026 Regentis Biomaterials Ltd. announced that the Japan Patent Office has issued a Notice of Allowance for its proprietary… Jul 20, 2026 On July 15, 2026, Regentis Biomaterials Ltd. announced it received European regulatory approval for a new GelrinC… Jul 15, 2026 On July 9, 2026, Regentis Biomaterials Ltd. announced that shareholders approved all fourteen proposals presented at… Jul 9, 2026 Regentis Biomaterials Ltd. adjourned its Annual General Meeting of Shareholders, originally scheduled for July 2… Jul 2, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
